Insights

Nature-positive value Invaio positions its technology as a nature-positive solution aimed at reducing pesticide use, water consumption, and CO2 emissions. This creates opportunities to pitch sustainability-driven savings and regulatory alignment to grower customers seeking greener operations and potential incentives.

Manufacturing collaboration Recent collaboration with Ginkgo Bioworks to develop manufacturing technology for peptide-based agricultural products indicates a strategic emphasis on scalable production. This opens doors for sales discussions around reliable supply, customization options, and faster time-to-market for peptide-based inputs.

Leadership updates New appointments of a Chief Science Officer and a CEO/Board leadership signal a strengthened strategic and scientific focus. Engage with decision-makers on advanced R&D pipelines, validation trials, and long-range product roadmaps that could impact small- to mid-size grower segments.

Regulatory milestones Successful FDACS approval for Citrus Health solution demonstrates regulatory progress and credibility. This can be leveraged when approaching citrus producers and other fruit/vegetable growers seeking compliant, risk-mitigated biopesticide and bioactives options.

Field-ready applications Launches like Trecise application technology and Peptyde Bio acquisition show a blend of application efficiency and expanded product capabilities. Position these as integrated spray-and-delivery solutions that can reduce chemical load and labor costs for growers seeking practical, low-touch adoption.

Similar companies to Invaio

Invaio Tech Stack

Invaio uses 8 technology products and services including GitHub, WordPress, Salesforce, and more. Explore Invaio's tech stack below.

Media & News

Invaio's Email Address Formats

Invaio uses at least 4 email formats:
Invaio Email FormatsExamplePercentage
FLast@invaio.comJDoe@invaio.com
96%
Last@invaio.comDoe@invaio.com
2%
FMiddleLast@invaio.comJMichaelDoe@invaio.com
1%
LFirst@invaio.comDJohn@invaio.com
1%

Frequently Asked Questions

What is Invaio's official website and social media links?

Minus sign iconPlus sign icon
Invaio's official website is invaio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Invaio generate?

Minus sign iconPlus sign icon
As of October 2026, Invaio's annual revenue is estimated to be $25M - $50M.

What is Invaio's SIC code and NAICS code?

Minus sign iconPlus sign icon
Invaio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Invaio have currently?

Minus sign iconPlus sign icon
As of October 2026, Invaio has approximately 86 employees across 3 continents, including North America, Europe and South America. Key team members include Chief Communications Officer: K. J., Chief Scientific Officer: G. R. and President R&d: G. R. Explore Invaio's employee directory with LeadIQ.

What industry does Invaio belong to?

Minus sign iconPlus sign icon
Invaio operates in the Biotechnology Research industry.

What technology does Invaio use?

Minus sign iconPlus sign icon
Invaio's tech stack includes GitHub, WordPress, Salesforce, Snowflake, Microsoft SQL Server, Google Workspace, Microsoft Active Directory and Notion.

What is Invaio's email format?

Minus sign iconPlus sign icon
Invaio's email format typically follows the pattern of FLast@invaio.com. Find more Invaio email formats with LeadIQ.

How much funding has Invaio raised to date?

Minus sign iconPlus sign icon
As of October 2026, Invaio has raised $139M in funding. The last funding round occurred on Oct 13, 2021 for $50M.

When was Invaio founded?

Minus sign iconPlus sign icon
Invaio was founded in 2018.
Invaio logo

Invaio

Biotechnology ResearchMassachusetts, United States51-200 Employees

Invaio is a Cambridge, Massachusetts-based biotechnology research company focused on agriculture, developing technologies to bolster crop health and resilience against key threats. Its solutions center on precision delivery of natural bioactives to crops, with potential to reduce pesticide use and lower water use and CO2 emissions. The work aims to improve crop-system health and overall environmental outcomes, benefitting crops, ecosystems, and people. The company operates within the bioplatform sector and is tied to Flagship Pioneering, positioning itself to advance nature-positive agriculture.

The primary customers are growers seeking to protect yields while reducing chemical inputs, water use, and emissions. A notable recent development is a collaboration with Ginkgo Bioworks to develop manufacturing technology for peptide-based agricultural products.

Section iconCompany Overview

Website
invaio.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $139M

    Invaio has raised a total of $139M of funding over 4 rounds. Their latest funding round was raised on Oct 13, 2021 in the amount of $50M as a Debt Financing.

  • $25M - $50M

    Invaio's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.